Critical clinical gaps in cancer precision nanomedicine development
Active targeting strategy is adopted in nanomedicine for cancer treatment. Personalizing the nanomedicine in accordance with patients' omics, under the precision medicine platform, is met with challenges in targeting ligand and matrix material selection at nanoformulation stage. The past 5-year...
| Published in: | Journal of Controlled Release |
|---|---|
| Main Author: | |
| Format: | Review |
| Language: | English |
| Published: |
Elsevier B.V.
2022
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127814501&doi=10.1016%2fj.jconrel.2022.03.055&partnerID=40&md5=71b6f899537e58020fe912e7ffd21014 |